Under construction – not a live service
Sign in
Not yet recruitingNo phase

Sustainable Inhaler Prescribing in Intermediate Care Units

Key facts

Who runs it
Consorci Sanitari de l'Alt Penedès i Garraf
Where
Spain1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
110 people, planned
Starts
Jan 2027
Expected to end
Dec 2028
Type of study
Interventional, 2 groups
Treatments tested
  • Multidisciplinary inhaler optimization intervention
Record updated
12 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Aged 18 years or older
  • Admitted to an intermediate care unit with a minimum stay of one week
  • Active prescription of a pressurized metered-dose inhaler in the electronic prescription system

Who cannot take part

  • End-of-life situation (last days or hours of life)
  • Admission to the psychogeriatric unit

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if a multidisciplinary review of inhaler treatment can increase the use of inhalers with a lower environmental impact in adults admitted to intermediate care units who use inhalers. The main questions it aims to answer are:

Read full original descriptionShow less

* Does the intervention change the percentage of each type of inhaler prescribed (pressurized metered-dose inhalers, dry powder inhalers, and soft mist inhalers) between admission and discharge? * Does the intervention improve treatment adherence and inhaler technique, reduce the use of rescue inhalers, and reduce carbon dioxide (CO2) emissions? Researchers will compare patients cared for by physicians who apply the intervention with patients cared for by physicians who do not yet apply it, to see if more patients switch to inhalers with a lower environmental impact.

Participants will:

* Have their inhaler prescription reviewed by a physician, who may change it when clinically appropriate, taking environmental impact into account * Have their adherence and inhaler technique assessed by a healthcare professional * Receive individual education on how to use their inhalers, if needed

The 2 groups in the trial

  • delayed interventionOther group

    Patients of two geriatricians; usual care in periods 1 and 2, multidisciplinary inhaler intervention in period 3

    Treatment: Multidisciplinary inhaler optimization intervention

  • early interventionOther group

    Patients of the other two geriatricians; usual care in period 1, multidisciplinary inhaler intervention in periods 2 and 3

    Treatment: Multidisciplinary inhaler optimization intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Potential of Intermediate Care Units to Reduce Environmental Impact Through Sustainable Inhaler Prescribing: a Quasi-experimental Study of a Multidisciplinary Clinical Intervention
Record updated
12 November 2026